Source:http://linkedlifedata.com/resource/pubmed/id/17549377
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-5
|
pubmed:abstractText |
Overexpression of the erbB-1 (EGFR, epidermal growth factor receptor) and erbB-2 (HER2/neu) proteins contributes to the aggressive behavior of malignant tumors originating from the endometrium. We currently examined whether the trend of these proteins to overexpression is a direct effect of their gene transcriptional activities. Expression of the erbB-1/erbB-2 genes was measured applying the quantitative RT-PCR technique in 25 uterine carcinomas, 12 normal endometria, a carcinosarcoma and a case of botryoid sarcoma of the uterine cervix. We showed that erbB-1 mRNA was overexpressed in 48% (12/25) and erbB-2 mRNA was overexpressed in 8% (2/25) of the analysed tumors. The level of expression appeared to be significantly higher in the malignant tumors as compared to the benign ones for erbB-1 and for erbB-2 (p=0.0001 and p=0.008, respectively). A significant correlation between erbB-1 overexpression and tumor differentiation was found (Spearman rank correlation test, p<0.001). Concomitant erbB-1 and erbB-2 overexpression was detected only in 1 out of 25 (4%) uterine neoplasms. erbB-1 was overexpressed in a sarcoma botryoides of the uterine cervix. Our data suggest that erbB-1/erbB-2 overexpression is a direct effect of higher than normal transcriptional activity of the encoding genes in a subset of human endometrial carcinomas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1021-335X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17549377-Adenocarcinoma, Clear Cell,
pubmed-meshheading:17549377-Aged,
pubmed-meshheading:17549377-Aged, 80 and over,
pubmed-meshheading:17549377-Carcinoma, Adenosquamous,
pubmed-meshheading:17549377-Endometrial Neoplasms,
pubmed-meshheading:17549377-Endometrium,
pubmed-meshheading:17549377-Female,
pubmed-meshheading:17549377-Humans,
pubmed-meshheading:17549377-Middle Aged,
pubmed-meshheading:17549377-RNA, Messenger,
pubmed-meshheading:17549377-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17549377-Receptor, erbB-2,
pubmed-meshheading:17549377-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17549377-Tumor Markers, Biological
|
pubmed:year |
2007
|
pubmed:articleTitle |
Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium.
|
pubmed:affiliation |
Department of Cytobiochemistry, University of Lodz, Lodz 90-237, Poland. zreg@biol.uni.lodz.pl
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|